CB Therapeutics
Advanced synthetic biology for planet and human health
Overview
Raised: $10,650
Total Commitments ($USD)
Republic
02/28/2023
04/30/2023
$25,000
$1,235,000
$250
SAFE
Series B
RegCF
$45,000,000
20%
Rolling Commitments ($USD)
Active
03/27/2023
34
43%
1%
$394
32
2015
Healthcare & Pharmaceuticals
Biotech
B2B
Medium
High
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$2,014,066 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$3,017 |
$1,600 |
| ||
| ||
|
Net Income |
$-1,772,158 |
$-2,278,343 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$1,810,709 |
$13,453 |
|
Accounts Receivable |
$14,066 |
$0 |
|
Total Assets |
$3,722,376 |
$910,015 |
|
Short-Term Debt |
$287,110 |
$677,795 |
|
Long-Term Debt |
$188,555 |
$730,988 |
|
Total Liabilities |
$475,665 |
$1,408,783 |
Upgrade to gain access
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Ratings 
